global pandemic – Page 2 – Communicable Diseases Research

Autoantibodies – enemies, and/or potential allies?

Article

Published on 2022-10-192022-11-15
Journal: Frontiers in Immunology
[Category] 진단,

ATP enhances the error-prone ribonucleotide incorporation by the SARS-CoV-2 RNA polymerase

Article

Published on 2022-10-152022-11-15
Journal: Biochemical and Biophysical Research Communication
[Category] COVID19(2023년), SARS, 치료제,

Deep Transfer Learning for COVID-19 Detection and Lesion Recognition Using Chest CT Images

Article

Published on 2022-10-152022-11-15
Journal: Computational and Mathematical Methods in Medicine
[Category] COVID19(2023년), SARS, 치료기술,

Galectin-3 binding protein stimulated IL-6 expression is impeded by antibody intervention in SARS-CoV-2 susceptible cell lines

Article

Published on 2022-10-112022-11-15
Journal: Scientific Reports
[Category] COVID19(2023년), SARS, 진단,

In-person training on COVID-19 case management and infection prevention and control: Evaluation of healthcare professionals in Bangladesh

Article

Published on 2022-10-042022-11-16
Journal: PLoS ONE
[Category] COVID19(2023년), SARS, 변종,

SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry

Article

Published on 2022-10-012022-11-16
Journal: Nature
[Category] COVID19(2023년), SARS, 유전자 메커니즘,

Calibration and Validation of a Mechanistic COVID-19 Model for Translational Quantitative Systems Pharmacology – A Proof-of-Concept Model Development for Remdesivir

Article

Published on 2022-10-012022-11-15
Journal: Clinical Pharmacology and Therapeutics
[Category] COVID19(2023년), SARS, 치료제,

[키워드] accelerate Administered antibody approach calibrated calibration clinical Clinical data Clinical outcome clinical setting clinical study Clinical trial design coronavirus disease Course COVID-19 COVID-19 disease COVID-19 therapeutics Cytokines development disease drug candidate example global pandemic immune responses immunological in silico include intravenously lymphopenia metabolism metabolite Mild Model Patient pharmacological Pharmacology Placebo predict provide quantitative framework Remdesivir responses severe COVID-19 System the disease the primary endpoint Therapies therapy Time to recovery translate validation viral titer virus infection
[DOI] 10.1002/cpt.2686 PMC 바로가기

Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review

오미크론의 분자적 측면, 백신 개발 및 재조합 균주 XE: 검토

Review

Published on 2022-10-012022-09-11
Journal: Journal of medical virology
[Category] COVID19(2023년), SARS, 변종, 치료기술, 치료제,

Brequinar and dipyridamole in combination exhibits synergistic antiviral activity against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19

Research article

Published on 2022-10-012022-10-05
Journal: Antiviral Research
[Category] COVID19(2023년), SARS, 변종, 치료법, 치료제,

[키워드] acute respiratory syndrome Antiviral antiviral activity Antiviral treatment B.1.351 B.1.617.2 Beta Brequinar cellular Combination coronavirus coronavirus disease COVID-19 de novo deaths Delta DHODH Dihydroorotate dehydrogenase (DHODH) Dipyridamole drug treatments effective enzyme evade Evolution of SARS-CoV-2 exhibit global pandemic Host host cell in vitro Infection infections inhibitor maintain medical need monoclonal antibody nucleotide pathway rationale Replication required resulting RNA virus SARS-CoV-2 SARS-COV-2 infection selective shown Support synergistic therapy treat Treatment Vaccine variants viral replication
[DOI] 10.1016/j.antiviral.2022.105403 [Article Type] Research article

Human coronaviruses: The emergence of SARS-CoV-2 and management of COVID-19

Review article

Published on 2022-10-012022-10-05
Journal: Virus research
[Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 임상, 치료기술, 치료제,